GSK plc (GLAXF)

USD 20.85

(0.63%)

Total Debt Summary of GSK plc

  • GSK plc's latest annual total debt in 2023 was 18.01 Billion GBP , down -14.15% from previous year.
  • GSK plc's latest quarterly total debt in 2024 Q1 was 17.77 Billion GBP , down -1.37% from previous quarter.
  • GSK plc reported annual total debt of 20.98 Billion GBP in 2022, down -13.18% from previous year.
  • GSK plc reported annual total debt of 24.17 Billion GBP in 2021, down -10.97% from previous year.
  • GSK plc reported quarterly total debt of 17.77 Billion GBP for 2024 Q1, down -1.37% from previous quarter.
  • GSK plc reported quarterly total debt of 21.47 Billion GBP for 2023 Q2, up 2.72% from previous quarter.

Annual Total Debt Chart of GSK plc (2023 - 1989)

Historical Annual Total Debt of GSK plc (2023 - 1989)

Year Total Debt Total Debt Growth
2023 18.01 Billion GBP -14.15%
2022 20.98 Billion GBP -13.18%
2021 24.17 Billion GBP -10.97%
2020 27.15 Billion GBP -11.01%
2019 30.5 Billion GBP 17.05%
2018 26.06 Billion GBP 52.52%
2017 17.08 Billion GBP -9.05%
2016 18.79 Billion GBP 12.97%
2015 16.63 Billion GBP -11.46%
2014 18.78 Billion GBP 2.95%
2013 18.24 Billion GBP -0.31%
2012 18.3 Billion GBP 22.82%
2011 14.9 Billion GBP -1.32%
2010 15.1 Billion GBP -7.12%
2009 16.25 Billion GBP 0.43%
2008 16.18 Billion GBP 53.13%
2007 10.57 Billion GBP 92.55%
2006 5.49 Billion GBP -15.16%
2005 6.47 Billion GBP 8.52%
2004 5.96 Billion GBP 16.85%
2003 5.1 Billion GBP 9.91%
2002 4.64 Billion GBP 9.46%
2001 4.24 Billion GBP 5.2%
2000 4.03 Billion GBP 14.87%
1999 3.51 Billion GBP 12.46%
1998 3.12 Billion GBP 3.28%
1997 3.02 Billion GBP -6.87%
1996 3.24 Billion GBP -27.4%
1995 4.47 Billion GBP 565.18%
1994 672 Million GBP -16.93%
1993 809 Million GBP 60.83%
1992 503 Million GBP -50.25%
1991 1.01 Billion GBP 115.57%
1990 469 Million GBP 169.54%
1989 174 Million GBP -34.09%

Peer Total Debt Comparison of GSK plc

Name Total Debt Total Debt Difference
AstraZeneca PLC 28.58 Billion USD 36.959%
Bristol-Myers Squibb Company PFD CONV 2 41.46 Billion USD 56.545%
CSPC Pharmaceutical Group Limited 99.64 Million USD -17982.015%
Clarus Therapeutics Holdings, Inc. 42.26 Million USD -42526.984%
Novartis AG 26.34 Billion USD 31.615%
PT Kalbe Farma Tbk. 40.4 Million USD -44492.648%